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We previously showed that crossreactivity is common between IAV and EBV in 
HLA-A2+ patients during infectious mononucleosis. IAV-M1-GIL58-66 specific CD8 T 
cells, along with expanded populations of IAV-M1-GIL58-66/EBV-BRLF-1109-117 -YVL and 
IAV-M1-GIL58-66/EBV-BMLF1280-288-GLC double-tetramer+ cells were detected directly 
ex-vivo in 5 HLA-A2+ patients.  Altered IAV-M158-66, EBV-BRLF1119-117 and -BMLF1280-288 
TCR repertoires were observed over the course of infection and in comparison to 
healthy donors. After culture, cells were sorted and analyzed by gene array in order to 
assess global changes in immune responses following different stimulations, either 
cognate or crossreactive, in different patient populations. M1-GIL and BRLF1-YVL 
specific cells had similar immune-response gene signatures, but the -GLC specific CD8 
cells were more similar to the two-crossreactive populations. Crossreactive M1-
GIL/BRLF1-YVL cells from the BRLF1-YVL line were different in their activation status 
than the BRLF1-specific cells, consistent with BRLF1-YVL ligand stimulation of different 
gene activation profiles in these two populations. These results suggest that during 
symptomatic IAV infection there is an expansion of EBV/IAV crossreactive memory CD8 
T cell responses. Ongoing studies are investigating whether EBV-IAV cross-reactive 
CD8+ T cells may contribute to immunopathology during acute IAV infection (NIH / 
NIAID PO1 AI 049320).  
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